Rigel Pharmaceuticals (RIGL) EBITDA Margin Growth (5y) (2015 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Quantum Biopharma | 961,148.99 Bn | 961,148.98 Bn | - |
| 2 | Alterity Therapeutics | 744,933.29 Bn | 744,933.26 Bn | - |
| 3 | Legend Biotech | 2,540.00 Bn | 2,539.71 Bn | 242.10 Mn |
| 4 | Nanobiotix | 2,199.85 Bn | 2,199.78 Bn | - |
| 5 | Akari Therapeutics | 1,635.88 Bn | 1,635.88 Bn | - |
| 6 | Vertex Pharmaceuticals | 111.32 Bn | 104.07 Bn | 2.59 Bn |
| 7 | Evaxion A | 62.56 Bn | 62.54 Bn | - |
| 8 | Regeneron Pharmaceuticals | 62.55 Bn | 53.79 Bn | 3.31 Bn |
| 9 | Alnylam Pharmaceuticals | 39.57 Bn | 36.56 Bn | 959.66 Mn |
| 10 | Rigel Pharmaceuticals | 551.62 Mn | 404.94 Mn | 54.21 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,133.00 |
| Dec 31, 2025 | 13,524.00 |
| Sep 30, 2025 | 11,586.00 |
| Jun 30, 2025 | 16,865.00 |
| Mar 31, 2025 | -1,376.00 |
| Dec 31, 2024 | 14,149.00 |
| Sep 30, 2024 | 8,313.00 |
| Jun 30, 2024 | 20,626.00 |
| Mar 31, 2024 | 12,199.00 |
| Dec 31, 2023 | -120.00 |
| Sep 30, 2023 | 48,505.00 |
| Jun 30, 2023 | 144,157.00 |
| Dec 31, 2022 | -58,058.00 |
| Sep 30, 2022 | 190,177.00 |
| Mar 31, 2022 | 29,514.00 |
| Dec 31, 2021 | 42,129.00 |
| Sep 30, 2021 | 51,292.00 |
| Jun 30, 2021 | 10,913.00 |
| Mar 31, 2021 | 40,085.00 |
| Dec 31, 2020 | 4,727.00 |
| Sep 30, 2020 | -2,276.00 |
| Jun 30, 2020 | 16,100.00 |
| Mar 31, 2020 | 87,522.00 |
| Dec 31, 2018 | 30,137.00 |
| Jun 30, 2018 | 17,348.00 |
| Mar 31, 2017 | 265,594.00 |
| Sep 30, 2016 | -19,050.00 |
| Jun 30, 2016 | 529,866.00 |
| Sep 30, 2015 | -12,185.00 |
| Jun 30, 2015 | -32,411.00 |